Association of cigarette smoking with albuminuria in the United States: The third national health and nutrition examination survey

Renal Failure

Volumn 29, Issue 2, 2007, Pages 133-142

  Hogan, Susan L ^a   Vupputuri, Suma ^a,b   Guo, Xuguang ^c   Cai, Jianwen ^b   Colindres, Romulo E ^a   Heiss, Gerardo ^b   Coresh, Josef ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c Statistics and Public Health Research Division   (United States)

Author keywords

Albuminuria; Chronic kidney disease; Hypertension; Risk factors; Smoking

Indexed keywords

COTININE;

ADULT; ALBUMINURIA; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY INJURY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SELF REPORT; SMOKING CESSATION; UNITED STATES;

ADOLESCENT; ADULT; ALBUMINURIA; CHILD; CHILD, PRESCHOOL; COTININE; HEALTH SURVEYS; HUMANS; INFANT; KIDNEY; MIDDLE AGED; NUTRITION ASSESSMENT; REFERENCE VALUES; SMOKING; UNITED STATES;

EID: 33847205308     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601098888     Document Type: Review

References (46)

1. Trosclair A, Husten C, Pederson L, Dhillon I. Cigarette smoking among adults - United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51:642-645.
2. Whelton PK, Randall B, Neaton J, Stamler J, Brancati FL, Klag M. Cigarette smoking and ESRD incidence in men screened for MRFIT. J Am Soc Nephrol. 1995;6:408A.
3. Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol. 2003;13:712-720.
4. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479-487.
5. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med. 1998;158:1933-1939.
6. Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM. Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol. 1997;145:91-102.
7. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, De Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med. 2000;133:585-591.
8. Culleton BF, Larson MG, Evans JC, Wilson PW, Barrett BJ, Parfrey PS, Levy D. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med. 1999;159:1785-1790.
9. Gambaro G, Verlato F, Budakovic A, Casara D, Saladini G, Del P, Bertaglia G, Masiero M, Checchetto S, Baggio B. Renal impairment in chronic cigarette smokers. J Am Soc Nephrol. 1998;9:562-567.
10. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844-850.
11. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2. 1992;113:21-35.
12. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Series 1, No. 32. Programs and Collection Procedures. Department of Health and Human Services Publication No. 94-1308. 1994:1-416.
13. Gunter EW, McQuillan G. Quality control in planning and operating the laboratory component for the Third National Health and Nutrition Examination Survey. J Nutr. 1990;120(Suppl. 11):1451-1454.
14. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7:930-937.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
16. Levey AS, Green T, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.
17. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920-929.
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39:S1-246.
19. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
20. Ramirez SB, Saleh A, Nandakumar M, Burford S, Lau TWL, Hsu SIH, Owen WF, McClellan W. Smoking is a risk factor for proteinuria as detected by screening in a large cohort of young adult Asians. J Am Soc Nephrol. 1999;10:87A.
21. Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, Atkins RC. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis. 2002;40:704-712.
22. Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab. 2000;26(Suppl. 4):54-63.
23. Lafayette RA, Perrone D, Levey AS. Laboratory evaluation of renal function. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney, 6th ed. Boston: Little, Brown and Company; 1997, 307.
24. Mlacak B, Jaksic Z, Vuletic S. Albuminuria, cardiovascular morbidity and mortality in diabetic and non-diabetic subjects in a rural general practice. Fam Pract. 1999;16:580-585.
25. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease - a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340:920-926.
26. He J, Whelton PK. Passive cigarette smoking increases risk of coronary heart disease. Eur Heart J. 1999;20:1764-1765.
27. Garland C, Barrett-Connor E, Suarez L, Criqui MH, Wingard DL. Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol. 1985;121:645-650.
28. Sandler DP, Comstock GW, Helsing KJ, Shore DL. Deaths from all causes in non-smokers who lived with smokers. Am J Public Health. 1989;79:163-167.
29. Svendsen KH, Kuller LH, Martin MJ, Ockene JK. Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1987;126:783-795.
30. Ciruzzi M, Pramparo P, Esteban O, Rozlosnik J, Tartaglione J, Abecasis B, Cesar J, De RJ, Paterno C, Schargrodsky H. Case-control study of passive smoking at home and risk of acute myocardial infarction. Argentine FRICAS Investigators. Factores de Riesgo Coronario en America del Sur. J Am Coll Cardiol. 1998;31:797-803.
31. Nyberg F, Isaksson I, Harris JR, Pershagen G. Misclassification of smoking status and lung cancer risk from environmental tobacco smoke in never-smokers. Epidemiology. 1997;8:304-309.
32. Nyberg F, Agudo A, Boffetta P, Fortes C, Gonzalez CA, Pershagen G. A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls. Cancer Causes Control. 1998;9:173-182.
33. Riggs JE. The "protective" influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology? Neurol Clin. 1996;14:353-358.
34. Keane WF, Kasiske BL, O'Donnell MP. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol. 1988;8:261-271.
35. Avram MM. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy. Am J Med 1989;87:39N-41N.
36. Diamond JR. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int Suppl. 1991;31:S29-S34.
37. Kamanna VS, Roh DD, Kirschenbaum MA. Atherogenic lipoproteins: mediators of glomerular injury. Am J Nephrol. 1993;13:1-5.
38. Grond J, van Goor H, Erkelens DW, Elema JD. Glomerular sclerotic lesions in the rat. Histochemical analysis of their macromolecular and cellular composition. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51:521-534.
39. McLigeyo SO. Smoking - an emerging risk factor for renal diseases. East Afr Med J. 1998;75:171-174.
40. Orth SR. Smoking - a renal risk factor. Nephron. 2000;86:12-26.
41. Auerbach O, Hammond EC, Garfinkel L. Thickening of walls of arterioles and small arteries in relation to age and smoking habits. N Engl J Med. 1968;278:980-984.
42. Black HR, Zeevi GR, Silten RM, Walker S. Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron. 1983;34:173-179.
43. Oberai B, Adams CW, High OB. Myocardial and renal arteriolar thickening in cigarette smokers. Atherosclerosis. 1984;52:185-190.
44. Tracy RE, Malcom GT, Oalmann MC, Newman WP, III, Guzman MA. Nephrosclerosis, glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease. Mod Pathol. 1994;7:301-309.
45. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand J Work Environ Health. 1998;24(Suppl. 1):1-51.
46. Satarug S, Moore MR. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect. 2004;112:1099-1103.